Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Bassil CF"'
Autor:
Meslin PA; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Kelly LM; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Benbarche S; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Lecourt S; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France.; Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France., Lin KH; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Rutter JC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Itzykson R; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France.; Department of Hematology, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Puissant A; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Lobry C; Université de Paris Cité, Inserm U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France.
Publikováno v:
NAR genomics and bioinformatics [NAR Genom Bioinform] 2024 May 25; Vol. 6 (2), pp. lqae059. Date of Electronic Publication: 2024 May 25 (Print Publication: 2024).
Autor:
Cerda-Smith CG; Department of Pharmacology and Cancer Biology, Duke University School of Medicine; Durham, NC 27710, USA., Hutchinson HM; Department of Pharmacology and Cancer Biology, Duke University School of Medicine; Durham, NC 27710, USA., Liu A; Department of Surgery, Duke University School of Medicine; Durham, NC 27710, USA., Goel VY; Department of Biological Engineering, Massachusetts Institute of Technology; Cambridge, 02139, USA.; Broad Institute; Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research; Cambridge, MA, 02139, USA., Sept C; Broad Institute; Cambridge, MA 02139, USA.; Department of Biostatistics, Harvard School of Public Health; Boston, MA 02215, USA., Kim H; Department of Radiation Oncology, Duke University School of Medicine; Durham, NC 27710, USA., Casaní-Galdón S; Broad Institute; Cambridge, MA 02139, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute; Boston, MA 02215, USA.; Departments of Cell Biology and Pathology, Harvard Medical School; Boston, MA 02114, USA., Burkman KG; Department of Radiation Oncology, Duke University School of Medicine; Durham, NC 27710, USA., Bassil CF; Department of Pharmacology and Cancer Biology, Duke University School of Medicine; Durham, NC 27710, USA., Hansen AS; Department of Biological Engineering, Massachusetts Institute of Technology; Cambridge, 02139, USA.; Broad Institute; Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research; Cambridge, MA, 02139, USA., Aryee MJ; Broad Institute; Cambridge, MA 02139, USA.; Department of Pathology, Harvard Medical School; Boston, MA 02114, USA.; Department of Data Science, Dana-Farber Cancer Institute; Boston, MA 02215, USA., Johnstone SE; Broad Institute; Cambridge, MA 02139, USA.; Department of Pathology, Dana-Farber Cancer Institute; Boston, MA 02215, USA., Eyler CE; Department of Radiation Oncology, Duke University School of Medicine; Durham, NC 27710, USA.; Duke Cancer Institute, Duke University School of Medicine; Durham, NC 27710, USA., Wood KC; Department of Pharmacology and Cancer Biology, Duke University School of Medicine; Durham, NC 27710, USA.; Duke Cancer Institute, Duke University School of Medicine; Durham, NC 27710, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 21. Date of Electronic Publication: 2023 Sep 21.
Autor:
Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Anderson GR; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Mayro B; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Askin KN; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Winter PS; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Gruber S; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hall TM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hoj JP; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Cerda-Smith C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hutchinson HM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Singleton KR; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Qin L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Jubien-Girard K; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272 - 06108 Nice, France., Favreau C; Université Côte d'Azur, INSERM, C3M, Nice, France., Martin AR; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272 - 06108 Nice, France.; IBMM, Université de Montpellier, ENSCM, CNRS, Montpellier, France., Robert G; Université Côte d'Azur, INSERM, C3M, Nice, France., Benhida R; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272 - 06108 Nice, France.; Chemical & Biochemical Sciences Green-Process Engineering (CBS) Mohammed VI Polytechnic University, Lot 660, Hay Moulay Rachid, Benguerir, Morocco., Auberger P; Université Côte d'Azur, INSERM, C3M, Nice, France., Pendergast AM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Lonard DM; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Puissant A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Jan 19. Date of Electronic Publication: 2023 Jan 19.
Autor:
Lin KH; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Rutter JC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Xie A; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Vaganay C; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Benaksas C; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Ling F; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Sodaro G; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Meslin PA; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Fenouille N; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Hoj J; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Washart R; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Ang HX; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Cerda-Smith C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Chaintreuil P; Université Côte d'Azur, Nice, France., Jacquel A; Université Côte d'Azur, Nice, France., Auberger P; Université Côte d'Azur, Nice, France., Forget A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Itzykson R; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Lu M; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Lin J; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Pierobon M; Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA, USA., Sheng Z; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Li X; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Chilkoti A; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Owzar K; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC, USA., Benajiba L; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Petricoin E; Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA, USA., Puissant A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France. alexandre.puissant@inserm.fr., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Jul; Vol. 3 (7), pp. 837-851. Date of Electronic Publication: 2022 Jun 06.
Autor:
Ali M; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Lu M; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Ang HX; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Soderquist RS; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Eyler CE; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Hutchinson HM; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Glass C; Department of Pathology, Duke University, Durham, NC 27710, USA., Bassil CF; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Lopez OM; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Kerr DL; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA., Falcon CJ; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA., Yu HA; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA., Hata AN; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA., Blakely CM; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA., McCoach CE; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA., Bivona TG; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA., Wood KC; Department of Pharmacology and Cancer Biology and Duke Cancer Institute, Duke University, Durham, NC 27710, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Mar 30; Vol. 14 (638), pp. eabc7480. Date of Electronic Publication: 2022 Mar 30.
Autor:
Su A; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Ling F; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Vaganay C; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Sodaro G; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Benaksas C; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Dal Bello R; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Forget A; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Pardieu B; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Lin KH; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina., Rutter JC; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina., Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina., Fortin G; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Pasanisi J; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Antony-Debré I; INSERM UMR 1287, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts., Benoist JF; AP-HP, Biochemistry-Hormonology Department, Robert Debré Hospital, Paris, France., Pruvost A; Paris-Saclay University, CEA, INRAE, Département Médicaments et Technologies pour la santé, SPI, Gif-sur-Yvette, France., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Qi J; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Schlageter MH; AP-HP, Cellular Biology Department, St Louis Hospital, Paris, France.; INSERM U 1131, IRSL, St Louis Hospital, University of Paris, Paris, France., Micol JB; INSERM UMR 1287, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France.; Department of Hematology, Gustave Roussy Institute, Villejuif, France., Roti G; University of Parma, Department of Medicine and Surgery, Parma, Italy., Cluzeau T; Department of Hematology, Centre Hospitalier Universitaire, Nice, France., Dombret H; LTL, IRSL, St Louis Hospital, Paris, France., Preudhomme C; Laboratory of Hematology, CHU Lille, Lille, France., Fenouille N; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France., Benajiba L; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France.; AP-HP, Hematology Department, St Louis Hospital, Paris, France., Golan HM; Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts., Lobry C; INSERM UMR 1287, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina., Itzykson R; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France. alexandre.puissant@inserm.fr raphael.itzykson@aphp.fr., Puissant A; INSERM UMR 944, IRSL, St Louis Hospital, University of Paris, Paris, France. alexandre.puissant@inserm.fr raphael.itzykson@aphp.fr.
Publikováno v:
Cancer discovery [Cancer Discov] 2020 Dec; Vol. 10 (12), pp. 1894-1911. Date of Electronic Publication: 2020 Aug 21.
Autor:
Fenouille N; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ben-Sahra I; Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts, USA., Benajiba L; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Bioinformatics Graduate Program, Boston University, Boston, Massachusetts, USA., Ramos A; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Burgess MR; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Li Q; Internal Medicine Hematology-Oncology, University of Michigan, Ann Arbor, Michigan, USA., Luciano F; Université Côte d'Azur, UMR INSERM U1065, C3M, Nice, France., Auberger P; Université Côte d'Azur, UMR INSERM U1065, C3M, Nice, France., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Zhang Y; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, New York, USA., Perkins AS; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, New York, USA., Shannon K; Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; INSERM UMR 944, Institut Universitaire d'Hématologie, Hôpital St. Louis, Paris, France., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature medicine [Nat Med] 2017 Mar; Vol. 23 (3), pp. 301-313. Date of Electronic Publication: 2017 Feb 13.
Autor:
Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Institut National de la Santé et de la Recherche Medicale U1065, Team 2, C3M, 06204 Nice, France., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142 Bioinformatics Graduate Program, Boston University, Boston, MA 02215., Furman A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Chen LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Frumm SM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Ross L; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Fenouille N; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Lewis CA; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Ramos A; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Gould J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Clish CB; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142., Kung AL; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Vander Heiden MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142 Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Banerji V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Research Institute of Oncology and Hematology at CancerCare Manitoba and the University of Manitoba, Winnipeg R3E OV9, Manitoba, Canada., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142 kimberly_stegmaier@dfci.harvard.edu.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2016 Jun 27; Vol. 213 (7), pp. 1285-306. Date of Electronic Publication: 2016 Jun 20.
Autor:
Boros K; Department of Histopathology, Manchester Royal Infirmary, Manchester, UK., Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; INSERM U1065, Team 2, C3M, Nice, France., Back M; The Medical School, The University of Manchester, Manchester, UK., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Sinha P; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Tholouli E; Department of Haematology, Manchester Royal Infirmary, Manchester, UK., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Byers RJ; Institute of Cancer Sciences, The University of Manchester, Manchester, UK., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2015 Sep 22; Vol. 6 (28), pp. 25575-87.
Autor:
Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Fenouille N; Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA., Robert G; 1] INSERM U1065, Team 2, C3M, Bâtiment Universitaire ARCHIMED, Nice, France [2] Université de Nice Sophia Antipolis, Nice, France [3] Equipe labellisée par la LNCC (2011-2013), Paris, France., Jacquel A; 1] INSERM U1065, Team 2, C3M, Bâtiment Universitaire ARCHIMED, Nice, France [2] Université de Nice Sophia Antipolis, Nice, France [3] Equipe labellisée par la LNCC (2011-2013), Paris, France., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Colosetti P; 1] INSERM U1065, Team 2, C3M, Bâtiment Universitaire ARCHIMED, Nice, France [2] Université de Nice Sophia Antipolis, Nice, France [3] Equipe labellisée par la LNCC (2011-2013), Paris, France., Luciano F; 1] INSERM U1065, Team 2, C3M, Bâtiment Universitaire ARCHIMED, Nice, France [2] Université de Nice Sophia Antipolis, Nice, France [3] Equipe labellisée par la LNCC (2011-2013), Paris, France., Auberger P; 1] INSERM U1065, Team 2, C3M, Bâtiment Universitaire ARCHIMED, Nice, France [2] Université de Nice Sophia Antipolis, Nice, France [3] Equipe labellisée par la LNCC (2011-2013), Paris, France [4] Centre Hospitalier Universitaire de Nice, Nice, France.
Publikováno v:
Cell death & disease [Cell Death Dis] 2014 Jul 24; Vol. 5, pp. e1349. Date of Electronic Publication: 2014 Jul 24.